The 14th World Clinical Biomarkers & Companion Diagnostics Summit is the premier event for diagnostic stakeholders, bringing together over 500 senior leaders in the fields of biomarkers, translational medicine, and precision medicine. This year’s agenda offers enhanced networking opportunities, uniting drug developers, diagnostics providers, payers, and coalitions to exchange insights and accelerate biomarker-driven clinical trials. With a focus on early disease biomarker discovery, clinical biomarker strategy, reimbursement clarity, and drug-diagnostics commercialization, the summit is essential for those shaping the future of precision medicine and improving patient outcomes.